A SA pharmaceutical company Xylomed Pharmaceuticals plans to launch a major clinical trial for an experimental Ebola treatment in African countries affected by recurring outbreaks of the deadly virus. – Business Day (9 July 2026)
Private healthcare funders should dump the various legal challenges against the National Health Insurance (NHI) – which were likely to drag on for another 10 years at least – and rather engage in dialogue to address their concerns, was the advice of experts at the annual Board of Healthcare Funders (BHF) conference. – MedicalBrief (9 July 2026).
Costly new generation weight loss drugs are unaffordable for most people, which has opened up a black market for cheaper, unregistered and untested versions of the medicines being sold across the country, posing a public health threat, as highlighted by a newspaper exposé and unpacked by Bhekisisa health journalists. – MedicalBrief (8 July 2026)
SA’s private healthcare sector is losing an estimated R40bn annually to fraud, corruption and procurement irregularities, delegates heard at the Board of Healthcare Funders (BHF) conference in Cape Town. – MedicalBrief (8 July 2026)